KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹0.18 Cr | ₹-0.70 Cr | ₹-0.20 Cr | ₹-0.61 Cr | ₹1.29 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KERALA AYURVEDA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹0.18 Cr |
Mar2023 | ₹-0.70 Cr |
Mar2022 | ₹-0.20 Cr |
Mar2021 | ₹-0.61 Cr |
Mar2020 | ₹1.29 Cr |
How is Deferred Tax Assets / Liabilities of KERALA AYURVEDA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.18 Cr | Positive | |
Mar2023 | ₹-0.70 Cr | Negative | |
Mar2022 | ₹-0.20 Cr | Negative | |
Mar2021 | ₹-0.61 Cr | Negative | |
Mar2020 | ₹1.29 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹509.8 Cr | -0.7% | -9.1% | 58.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | -0.7% |
-9.1% |
58.4% |
SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses